BURNETT JOSEPH 4

What Happened

• Joseph M. Burnett, CEO, President and a director of ClearPoint Neuro (CLPT), exercised 20,000 options at $2.50 per share (cost $50,000) and, on the same day (2026-06-29), sold 20,000 shares in an open-market transaction at a weighted average price of $19.38 for total proceeds of approximately $387,600. The filing also reports a 20,000-share derivative disposition listed at $0 (see footnotes for ownership/vesting details).
• The sequence (exercise then same-day sale of an equal number of shares) functions effectively as a cashless exercise followed by a sale—i.e., Burnett did not retain those newly exercised shares as a long-term open-market holding.

Key Details

• Transaction date: 2026-06-29; Form 4 filed 2026-07-01 (timely within required reporting window).
• Exercise: 20,000 shares @ $2.50 = $50,000 paid.
• Sale: 20,000 shares @ weighted avg $19.38 = ~$387,600 proceeds (sales ranged $19.15–$19.54 per F2).
• Additional derivative disposition: 20,000 shares @ $0 reported (transaction code M; details not expanded in excerpt).
• Shares owned after transaction: not provided in the excerpt of the filing.
• Notable footnotes: trades were made under a Rule 10b5-1 trading plan adopted June 11, 2025 (F1); the shares are held by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Burnett as trustee (F3); vesting schedule for the option grant (Nov 7, 2017) is described (F4).

Context

• This is a routine insider sale tied to option exercise and a prearranged 10b5-1 plan; sales like this do not necessarily signal a negative view of the company. Because the exercised shares were sold the same day, Burnett did not increase his public holding through this transaction.